RVMD - Nilai pasar Revolution Medicines

The Revolution Medicines (RVMD) share price visualized below on the GURU.Markets platform stands at 41.62, with the company's success depending on clinical trial outcomes and the management of development costs. The business relies on creating unique targeted therapies against complex mutations, establishing a foundation of irreplaceable treatment options. Leadership in precision oncology and robust R&D investments confirm its status as a technological innovator.

revmed.com - Kapitalisasi pasar RVMD (periode 04.07.2022 - 22.10.2026)

Rincian metrik lan analitis perusahaan Revolution Medicines Corp (RVMD)

Revolution Medicines (RVMD): dhaptar indikator lan metrik:

Kutipan saham Revolution Medicines, Inc.|RVMD - Bagan rega target|Nilai pasar Revolution Medicines Corp

Pambiji fundamental perusahaan:Revolution Medicines, Inc. RVMD

Sampel barang Revolution Medicines

The market capitalization of Revolution Medicines (RVMD) reflects the aggregate value of all outstanding shares, serving as a gauge of the company's market standing amidst a fierce scientific race for leadership in oncology. By analyzing the issuer's capitalization, an investor assesses the total business value excluding debt, which allows for the determination of the asset's fair price based on expectations of future clinical breakthroughs and patents.

Pesaing Revolution Medicines (RVMD)

BeiGene - Biji pasar|Halozyme Therapeutics, Inc. - Nilai pasar|AAPG - Nilai pasar|CG Oncology Therapeutics (CGON) - Biji pasar|URGN: Kapitalisasi pasar|Kapitalisasi pasar BCAX|PSNL (Personalis) - Kapitalisasi pasar|Biji pasar Erasca Inc (ERAS)|Kapitalisasi pasar DCTH|Kapitalisasi pasar Y-mAbs Corp (YMAB)|Nilai pasar Aura Biosciences, Inc. AURA|CADL: Kapitalisasi pasar|Accuray - Kapitalisasi pasar|SELLAS Life Sciences (SLS) - Biji pasar|ACTU: Kapitalisasi pasar|Nilai pasar Citius Oncology Inc (CTOR)|Nilai pasar TuHURA Biosciences Inc.|TARA: Nilai pasar|Biji pasar FATE (Fate Therapeutics)|WHWK (aadibio.com) - Nilai pasar|Kapitalisasi pasar TCRX (TScan Therapeutics, Inc.)|CSBR - Biji pasar|XBIT: Biji pasar|CVM - Kapitalisasi pasar|OS Therapies (OSTX) - Nilai pasar|Radiopharm Theranostics Ltd - Nilai pasar|ARTV (Artiva Biotherapeutics Inc.) - Kapitalisasi pasar|Nilai pasar Adlai Nortye Limited ANL|Nilai pasar Veru Inc. (VERU)|TPST (tempesttx.com) - Nilai pasar|Kapitalisasi pasar XLO (Xilio Therapeutics)|Renovaro Biosciences (RENB) - Nilai pasar|MURA: Biji pasar|KAPA: Nilai pasar|onkuretherapeutics.com (OKUR) - Nilai pasar|Nilai pasar CytoMed Therapeutics Limited (GDTC)|Nilai pasar Curis Inc.|Nilai pasar APLM|Biji pasar THAR (Tharimmune Corp)|Kapitalisasi pasar advanbiomed.com (ADVB)|Genprex, Inc. - Biji pasar|Nilai pasar CLDI (Calidi Biotherapeutics Inc.)|Sunshine Biopharma - Kapitalisasi pasar|Kapitalisasi pasar Xenetic Biosciences XBIO|Salarius (SLRX) - Nilai pasar|Nilai pasar Kitov Pharma (PPBT)|Nilai pasar American Oncology Network Inc|Kapitalisasi pasar BGNE (beigene.com)|Biji pasar CKPT (Checkpoint Therapeutics, Inc.)|ELEV (Elevation Oncology Inc.) - Nilai pasar|Nilai pasar iCAD ICAD|IKNA - Biji pasar|Notable Labs, Ltd. - Kapitalisasi pasar|Nilai pasar Viracta Therapeutics|MOR: Kapitalisasi pasar|Kapitalisasi pasar NAYA|AAPGV (Ascentage Pharma Group Ltd) - Kapitalisasi pasar